Literature DB >> 26418242

Trends in Pertussis Diagnostic Testing in the United States, 1990 to 2012.

Amanda E Faulkner1, Tami H Skoff, M Lucia Tondella, Amanda Cohn, Thomas A Clark, Stacey W Martin.   

Abstract

BACKGROUND: Reports of pertussis have been increasing in the US since the 1990s, and pertussis diagnostics have evolved during that time. Here, we describe temporal changes in pertussis diagnostic practices in the US during 1990 to 2012 and discuss potential implications.
METHODS: Pertussis cases reported through the National Notifiable Diseases Surveillance System during 1990 to 2012 were included in this analysis. Laboratory results were stratified by test type, case classification, age group and case-patient state of residence.
RESULTS: This analysis included 291,290 cases with 64% (n = 186,766) reporting at least 1 pertussis laboratory result. Culture and direct fluorescent antibody were the primary results reported during the early 1990s; however, polymerase chain reaction (PCR) surpassed all other test types during the late 1990s and 2000s. By 2012, more than 91% of cases with known results were tested using PCR, either alone or in combination with another test type. Before 2005, Massachusetts reported 71% of serology results, but an increasing number of states reported serologic results during 2005 to 2012. When stratified by age group, overall testing trends persist. As of 2012, culture confirmation is used infrequently across all ages, whereas the use of serology increases with age and is most prevalent among adults aged ≥ 20 years.
CONCLUSIONS: PCR has become the primary diagnostic method, and serologic assays now are used in a majority of states. Epidemiologic trends must be considered in the context of changing diagnostic tests, and modifications to surveillance case definitions should be considered to better reflect current testing practices.

Entities:  

Mesh:

Year:  2016        PMID: 26418242     DOI: 10.1097/INF.0000000000000921

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  10 in total

1.  Geospatial analysis of nonmedical vaccine exemptions and pertussis outbreaks in the United States.

Authors:  Carlin Aloe; Martin Kulldorff; Barry R Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-20       Impact factor: 11.205

Review 2.  Forty Years of Molecular Diagnostics for Infectious Diseases.

Authors:  Jonathan E Schmitz; Charles W Stratton; David H Persing; Yi-Wei Tang
Journal:  J Clin Microbiol       Date:  2022-07-19       Impact factor: 11.677

3.  Large pertussis outbreak in rural Canada: Lessons learned from Haida Gwaii.

Authors:  Tracy Morton; Catherine Birtwistle; Raina Fumerton; Sandra Allison
Journal:  Can Fam Physician       Date:  2018-07       Impact factor: 3.275

4.  Complete Genome Sequence of Bordetella pertussis Strain VA-190 Isolated from a Vaccinated 10-Year-Old Patient with Whooping Cough.

Authors:  Joshua C Eby; Lauren Turner; Bryan Nguyen; June Kang; Carly Neville; Louise Temple
Journal:  Genome Announc       Date:  2016-09-15

5.  Evaluating the role of cough duration in the pertussis case definition among Michigan cases, 2000-2010.

Authors:  Jennifer K Knapp; Mark L Wilson; Susan Murray; Matthew L Boulton
Journal:  Prev Med Rep       Date:  2019-08-16

6.  [Clinical-epidemiological study of Bordetella pertussis infection in the Gran Canaria island in the period, 2008-2016].

Authors:  Laura Iglesias; Antonio Casabella Pernas; Melisa Hernández Febles; Elena Colino Gil; Alicia Eisman Maraver; María José Pena López
Journal:  An Pediatr (Engl Ed)       Date:  2017-12-06

7.  Acellular Pertussis Vaccine Inhibits Bordetella pertussis Clearance from the Nasal Mucosa of Mice.

Authors:  Jana Holubová; Ondřej Staněk; Ludmila Brázdilová; Jiří Mašín; Ladislav Bumba; Andrew R Gorringe; Frances Alexander; Peter Šebo
Journal:  Vaccines (Basel)       Date:  2020-11-19

Review 8.  Rediscovering Pertussis.

Authors:  Manuela Zlamy
Journal:  Front Pediatr       Date:  2016-06-08       Impact factor: 3.418

9.  Clinical-epidemiological study of Bordetella pertussis infection in the Gran Canaria island in the period, 2008-2016.

Authors:  Laura Iglesias; Antonio Casabella Pernas; Melisa Hernández Febles; Elena Colino Gil; Alicia Eisman Maraver; María José Pena López
Journal:  An Pediatr (Engl Ed)       Date:  2018-07-21

10.  Seroprevalence of Bordetella pertussis among a nationally representative sample of Iranian pediatric population: The childhood and adolescence surveillance and prevention of adult noncommunicable disease-V study.

Authors:  Zary Nokhodian; Behrooz Ataei; Seyed Mohsen Zahraei; Mohammad Mehdi Gouya; Shervin Ghaffari Hoseini; Majid Yaran; Marjan Mansourian; Mohammad Esmaeil Motlagh; Ramin Heshmat; Roya Kelishadi
Journal:  J Res Med Sci       Date:  2021-03-31       Impact factor: 1.852

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.